EIGER BIOPHARMACEUTICALS INC's ticker is EIGR and the CUSIP is 28249U105. A total of 51 filers reported holding EIGER BIOPHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $10,896 | -59.5% | 32,430 | 0.0% | 0.00% | -50.0% |
| Q2 2023 | $26,884 | -7.6% | 32,430 | 0.0% | 0.00% | -33.3% |
| Q1 2023 | $29,086 | -32.1% | 32,430 | 0.0% | 0.00% | -57.1% |
| Q4 2022 | $42,808 | -74.1% | 32,430 | 0.0% | 0.01% | -90.0% |
| Q3 2022 | $165,000 | -37.5% | 32,430 | 0.0% | 0.07% | -39.1% |
| Q2 2022 | $264,000 | +24.5% | 32,430 | 0.0% | 0.12% | +38.6% |
| Q1 2022 | $212,000 | +57.0% | 32,430 | 0.0% | 0.08% | +48.2% |
| Q4 2021 | $135,000 | -38.4% | 32,430 | 0.0% | 0.06% | -32.5% |
| Q3 2021 | $219,000 | -18.6% | 32,430 | 0.0% | 0.08% | -18.6% |
| Q2 2021 | $269,000 | -7.2% | 32,430 | 0.0% | 0.10% | -17.7% |
| Q1 2021 | $290,000 | -23.5% | 32,430 | 0.0% | 0.12% | -28.7% |
| Q4 2020 | $379,000 | – | 32,430 | – | 0.17% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Knoll Capital Management, LLC | 694,232 | $8,532,000 | 5.82% |
| P.A.W. CAPITAL CORP | 400,000 | $4,916,000 | 4.34% |
| Telemetry Investments, L.L.C. | 128,848 | $1,584,000 | 2.68% |
| Trellus Management Company, LLC | 206,404 | $2,537,000 | 2.09% |
| KNOTT DAVID M | 295,035 | $3,626,000 | 1.64% |
| 683 Capital Management, LLC | 2,683,600 | $32,982,000 | 1.56% |
| INTERWEST VENTURE MANAGEMENT CO | 764,918 | $9,401,000 | 1.17% |
| TOWERVIEW LLC | 130,000 | $1,598,000 | 1.14% |
| Vivo Capital, LLC | 1,791,257 | $22,015,000 | 0.98% |
| Altium Capital Management LP | 197,500 | $2,427,000 | 0.91% |